Multimodal Cohort Study of Generalized Anxiety Disorder
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 400 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 10 November 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Meets the ICD-10 diagnostic criteria for generalized anxiety disorder (GAD). Aged 18 to 65 years. Hamilton Anxiety Rating Scale (HAMA) total score >14. Has at least a junior high school education and is able to complete self-report questionnaires
- Voluntarily agrees to participate in the study and provides written informed consent
Who cannot take part
- Meets ICD-10 diagnostic criteria for any psychiatric disorder other than GAD, as assessed using the Mini International Neuropsychiatric Interview (M.I.N.I.)
- Has a clinically significant medical condition or clinically significant laboratory abnormalities
- Has significant suicidal ideation or is considered to be at high risk of suicide
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Generalized anxiety disorder (GAD) is a common mental health condition characterized by persistent and excessive worry that is difficult to control. It can affect sleep, daily functioning, work, and quality of life. Some individuals experience long-lasting or recurrent symptoms, but the factors that influence the course and outcome of GAD are still not fully understood.
Read full original descriptionShow less
The main purpose of this study is to establish a long-term cohort of people with GAD and to better understand how their symptoms and health change over time. The study will also explore factors that may help predict symptom improvement, recurrence, and treatment outcomes.
Approximately 400 adults with GAD who receive care at Shanghai Mental Health Center will participate in this study. Participants will undergo regular clinical assessments and follow-up visits.
During the study, researchers will collect information about participants' symptoms, medical and treatment history, blood samples, and brain-related measurements. Participants will be followed at several time points to observe changes in symptoms and health. The information collected will be used to better understand the course of GAD and to support the development of more individualized approaches to diagnosis, treatment, and long-term care.
The group in the trial
- GAD Cohort
Participants diagnosed with generalized anxiety disorder (GAD) who receive routine clinical care. No specific treatment or intervention is assigned by the study protocol. Participants will be followed longitudinally, and information on clinical symptoms, treatments, blood samples, and multimodal neurophysiological and neuroimaging measures will be collected according to the study schedule.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Cohort Study of Generalized Anxiety Disorder Based on Multimodal Data
- Fit questions
- Built from NCT07764211, who can take part
- Record updated
- 10 November 2026